Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Huang KM, Zavorka Thomas M, Magdy T, Eisenmann ED, Uddin ME, DiGiacomo DF, Pan A, Keiser M, Otter M, Xia SH, Li Y, Jin Y, Fu Q, Gibson AA, Bonilla IM, Carnes CA, Corps KN, Coppola V, Smith SA, Addison D, Nies AT, Bundschuh R, Chen T, Lustberg MB, Wang J, Oswald S, Campbell MJ, Yan PS, Baker SD, Hu S, Burridge PW, Sparreboom A. Huang KM, et al. Among authors: hu s. Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2020168118. doi: 10.1073/pnas.2020168118. Proc Natl Acad Sci U S A. 2021. PMID: 33495337 Free PMC article.
Interaction of imatinib with human organic ion carriers.
Hu S, Franke RM, Filipski KK, Hu C, Orwick SJ, de Bruijn EA, Burger H, Baker SD, Sparreboom A. Hu S, et al. Among authors: hu c. Clin Cancer Res. 2008 May 15;14(10):3141-8. doi: 10.1158/1078-0432.CCR-07-4913. Clin Cancer Res. 2008. PMID: 18483382 Free article.
Pharmacogenetic pathway analysis of docetaxel elimination.
Baker SD, Verweij J, Cusatis GA, van Schaik RH, Marsh S, Orwick SJ, Franke RM, Hu S, Schuetz EG, Lamba V, Messersmith WA, Wolff AC, Carducci MA, Sparreboom A. Baker SD, et al. Among authors: hu s. Clin Pharmacol Ther. 2009 Feb;85(2):155-63. doi: 10.1038/clpt.2008.95. Epub 2008 May 28. Clin Pharmacol Ther. 2009. PMID: 18509327 Free PMC article.
Pharmacokinetic considerations for new targeted therapies.
Baker SD, Hu S. Baker SD, et al. Among authors: hu s. Clin Pharmacol Ther. 2009 Feb;85(2):208-11. doi: 10.1038/clpt.2008.242. Epub 2008 Dec 17. Clin Pharmacol Ther. 2009. PMID: 19092780 Free PMC article. Review.
Inhibition of OCTN2-mediated transport of carnitine by etoposide.
Hu C, Lancaster CS, Zuo Z, Hu S, Chen Z, Rubnitz JE, Baker SD, Sparreboom A. Hu C, et al. Among authors: hu s. Mol Cancer Ther. 2012 Apr;11(4):921-9. doi: 10.1158/1535-7163.MCT-11-0980. Epub 2012 Mar 2. Mol Cancer Ther. 2012. PMID: 22389472 Free PMC article.
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
de Graan AJ, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE, de Bruijn P, Hu S, Gibson AA, Bruun GH, Corydon TJ, Mikkelsen TS, Walker AL, Du G, Loos WJ, van Schaik RH, Baker SD, Mathijssen RH, Sparreboom A. de Graan AJ, et al. Among authors: hu s. Clin Cancer Res. 2012 Aug 15;18(16):4433-40. doi: 10.1158/1078-0432.CCR-12-0761. Epub 2012 Jun 18. Clin Cancer Res. 2012. PMID: 22711709 Free PMC article.
OATP1B1 polymorphism as a determinant of erythromycin disposition.
Lancaster CS, Bruun GH, Peer CJ, Mikkelsen TS, Corydon TJ, Gibson AA, Hu S, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A. Lancaster CS, et al. Among authors: hu s. Clin Pharmacol Ther. 2012 Nov;92(5):642-50. doi: 10.1038/clpt.2012.106. Epub 2012 Sep 19. Clin Pharmacol Ther. 2012. PMID: 22990751 Free PMC article. Clinical Trial.
18,614 results
You have reached the last available page of results. Please see the User Guide for more information.